Stay updated on Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a Study Status entry and removed an older version date in the record history.
    Difference
    0.2%
    Check dated 2026-04-03T19:24:19.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3. This appears to be a UI/backend update with no changes to study data or functionality.
    Difference
    0.1%
    Check dated 2026-03-20T06:38:03.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed in the study record history.
    Difference
    0.1%
    Check dated 2026-03-05T19:44:03.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added and an older revision (v3.4.1) was removed. The latest version also includes the 'Study Status' section in the history view.
    Difference
    0.3%
    Check dated 2026-02-12T02:06:14.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The history shows a new revision entry for v3.4.1 and the deletion of the previous revision v3.4.0. It reflects an administrative update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-02-04T22:50:41.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The history page adds a glossary toggle and a legend for color-coded changes (green for additions, red for deletions) in the study record view, and updates the footer to Revision: v3.4.0 with minor text tweaks such as capitalization changes for 'No FEAR Act'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-01-28T17:20:26.000Z thumbnail image

Stay in the know with updates to Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.